Investing in

science & engineering

from top Australian research

We partner with scientists and engineers with the power to reshape industries and solve the planet’s hardest problems.

Where we invest

Human Health
Product and services advancing the standard of care
Advanced Computing
Next-generation processing and computational systems
Physical World
Addressing the environmental challenges facing our world

When we invest

The red cross marked in the diagram(s) is where we often begin our journey with founders at Stoic. At this stage, we require startups to have demonstrated proof of concept (POC) of their research.

Our goal is to partner with founders looking to transform research into catalytic technologies. These are technologies which materialise into commercially viable products at great velocity.

Our cheques range anywhere from as small as 100k to 1M.

How we invest

Meeting #1
IC1 Review
Meeting #2
Due Diligence
IC2 Review
Offer
See full chart
Uniseed IC
First Meeting
Due Diligence
IC Decision
Offer
See full chart

Highlights

Kinoxis

Developing next generation therapeutics for behavioural and cognitive disorders.

Neurode

Personalised brain stimulation to boost focus and cognitivefunction.

BioScout

Preventing airborne diseases in agriculture with cutting-edge technology that helps farmers proactively manage crops.

Australia’s 1st University Fund

Partnered since 2019 giving you direct access to investors, operators and academics.
10 of the top research institutions in Australia
20 years experience in commercialisation
Leading superannuation fund Unisuper
+23

Multidisciplinary team

Decades of experience in building, scaling and fundraising with a deep network people ready to roll up their sleeves.
Harikesh Pushpapathan
Partner
Guy Hedley
Co-Founder & Partner
Dr Geoff Waring
Co-founder and Venture Partner
Diego Gourgues
Chief Financial Officer

Get in Touch.

Location
1 Macquarie Pl, Sydney NSW 2000
Operating hours
Monday to Friday, 9:00 AM - 5:00 PM